Carolinas Wealth Consulting’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-477
Closed -$9.73K 1070
2023
Q1
$9.73K Buy
+477
New +$9.6K ﹤0.01% 611
2022
Q4
Sell
-990
Closed -$20K 1073
2022
Q3
$20K Buy
+990
New +$19.7K 0.01% 442
2022
Q2
Sell
-822
Closed -$15K 890
2022
Q1
$15K Buy
+822
New +$15.1K ﹤0.01% 533

Other funds holding BTAL

Carolinas Wealth Consulting's BTAL Position: Q2 2023 in Review

Carolinas Wealth Consulting sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 477 shares — an estimated $9.73K sold.

Carolinas Wealth Consulting first reported a position in BTAL in Q1 2022 and held it in 3 quarters. The position peaked at $20K in Q3 2022. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • Carolinas Wealth Consulting reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 477 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $9.73K.
  • Carolinas Wealth Consulting first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2022 and held it in 3 quarters.
  • Carolinas Wealth Consulting's AGF US Market Neutral Anti-Beta Fund position peaked at $20K in Q3 2022.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2023, filed 14 Aug 2023.